CuraScientific Corp. is a bioscience company, which engages in the manufacture of commercial chemical products with applications in commercial sterilization for agriculture, warehousing, hospitality, and medical facilities. The company is headquartered in Nevada City, California. The company went IPO on 2001-10-16. The company has developed an effective germ fighter, DiOx+, a disinfectant sterilizer that kills 99.99% of harmful pathogens without dangerous toxic exposure to the user or the environment. Its DiOx+ is an activated chlorine dioxide (Cl02) broad spectrum disinfectant that kills dangerous pathogens with no residual toxicity. The company protects the environment and human health from viruses, bacteria and harmful by-products left by other cleaning sanitizers, without a harsh smell or skin irritation. DiOx+ helps protect agricultural crops from disease and other pathogens like mold and fungus. The company is used in water treatment plants, and helps reduce operational costs in warehousing, distribution centers, and ecommerce support facilities.
How did CSTF's recent EPS compare to expectations?
The most recent EPS for Curascientific Corp is $, expectations of $.
How did Curascientific Corp CSTF's revenue perform in the last quarter?
Curascientific Corp revenue for the last quarter is $
What is the revenue estimate for Curascientific Corp?
According to of Wall street analyst, the revenue estimate of Curascientific Corp range from $ to $
What's the earning quality score for Curascientific Corp?
Curascientific Corp has a earning quality score of /. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Curascientific Corp report earnings?
Curascientific Corp next earnings report is expected in
What are Curascientific Corp's expected earnings?
Curascientific Corp expected earnings is $, according to wall-street analysts.
Did Curascientific Corp beat earnings expectations?
Curascientific Corp recent earnings of $ expectations.